Madison-based Exact Sciences will be acquired by Abbott Laboratory for roughly $23 billion in a deal that was announced Nov.

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and ...

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, will present 10 abstracts ...

Founded near Boston in 1995, the company grew to become a biotech giant largely on the strength of its Cologuard cancer ...

From Cologuard Plus, to Medicare coverage and layoffs, it’s been a busy year for the Madison-based biotech giant.

After the deal closes, Abbott says Exact Sciences will maintain its presence in Madison. Exact Sciences CEO Kevin Conroy will ...

Exact Sciences markets Cologuard as a non-invasive, convenient test. The traditional method of testing for colorectal cancer ...

Pharmaceutical company Abbott will be acquiring Madison-based cancer research company Exact sciences for $21 billion, the ...

MADISON (WKOW) -- Abbott announced it will acquire Exact Sciences for an approximate enterprise value of $23 billion. Exact ...

Global healthcare leader Abbott announced Thursday that it has reached a $23 billion deal to acquire Exact Sciences.

Abbott agrees to acquire Exact Sciences for an estimated value up to $23 billion. The acquisition will include Exact Sciences' cancer ...

Abbott will acquire Madison-based cancer diagnostics company Exact Sciences in a $21 billion deal, expanding its global diagnostics portfolio.